US market today: Pfizer posts strong first-quarter, sees boost from recent legal winsPfizer reported higher-than-expected sales and profit on Tuesday and said a patent extension for its Vyndamax heart drug and a recent favor...
05 May, 2026, 09.04 PM IST
The alchemist of Bengaluru: Kiran Mazumdar-Shaw began from a garageKiran Mazumdar-Shaw has named her niece Claire Mazumdar as successor, setting up a gradual leadership transition at Biocon. A pioneer who b...
05 May, 2026, 05.35 PM IST
Bristol Myers partners with Microsoft for AI-driven lung cancer detectionBristol Myers Squibb is joining forces with Microsoft. They will use artificial intelligence to find lung cancer earlier. This technology a...
20 Jan, 2026, 07.35 PM IST
Syngene expands research collaboration with Bristol Myers SquibbSyngene International has extended its research partnership with Bristol Myers Squibb until 2035. This expanded agreement covers more servi...
19 Jan, 2026, 08.41 PM IST
Bristol Myers to set up drug development centre in HyderabadThe New Jersey-based drug maker has chosen Hyderabad to establish the proposed centre, and intends to begin operations towards the end of 2...
02 Mar, 2023, 12.41 AM IST
Natco Pharma's Canadian unit signs pact with Celgene for cancer treatment drugNatco Pharma entered into an agreement with biopharmaceutical firm Celgene for Lenalidomide capsules, which is used to treat various types ...
10 Jul, 2020, 12.48 PM IST
Biocon arm widens partnership terms with Bristol-Myers SquibbAs part of the expansion, Syngene will set up a new dedicated facility spread across 25,000 sq ft of laboratory and office space for Bristo...
14 Nov, 2017, 11.33 AM IST
Natco Pharma signs agreement for manufacturing, sale of hepatitis C drugDaclatasvir, discovered and developed by Bristol-Myer Squibb, is the first-in-class NS5A inhibitor used in combination with Sofosbuvir to t...
21 Jan, 2016, 11.36 AM IST
Biocon’s unit extends partnership with US-based Bristol-Myers SquibbThe two cos announced to renew their engagement, boosted by encouraging results in last 5 years, during when 6 drug molecules have been bro...
04 Jun, 2014, 06.43 PM IST
- Biocon inks pact with Bristol-Myers for insulin drug candidate IN-105
Biotechnology major Biocon today said it has entered into an agreement with Bristol-Myers Squibb for it's oral insulin new drug candidate I...
16 Nov, 2012, 02.06 PM IST
- Biocon close to oral insulin deal with Bristol-Myers Squibb
Four months after its partnership with Pfizer fell through, Biocon is now close to inking a deal with US-based biopharmaceuticals giant Bri...
25 Jul, 2012, 02.33 PM IST
- Bristol-Myers Squibb to acquire Amylin for USD 5.3 billion
Bristol-Myers Squibb will acquire drug maker Amylin for USD 5.3 billion, a move that will strengthen its position in the diabetic medicines...
30 Jun, 2012, 07.48 PM IST
- Bristol-Myers offers $3.5 bn for Amylin: Reports
Shares of Amylin Pharmaceuticals Inc rose as much as 51 percent as the company rejected a $3.5 billion unsolicited takeover bid from Bristo...
28 Mar, 2012, 08.26 PM IST
- Bristol-Myers to sell medical imaging unit
Drug developer Bristol-Myers Squibb said on Monday it will sell its medical imaging unit to private equity firm Avista Capital Partners for...
19 Dec, 2007, 02.17 AM IST
- Glenmark gets US nod for pravastatin sodium
Glenmark Pharmaceuticals announced on Wednesday that it had received approval in the US to market a generic version of Bristol Myers Squibb...
17 May, 2007, 02.55 AM IST
- Syngene signs agreement with Bristol-Myers
Biocon’s subsidiary company Syngene said it has entered into a research partnership with Bristol-Myers Squibb.
16 Mar, 2007, 03.27 AM IST
- Biocon subsi ties up with Bristol-Myers Squibb
Integrated biotechnology firm Biocon on Wednesday said its subsidiary Syngene has entered into a research partnership with global pharma ma...
14 Mar, 2007, 11.00 AM IST